Command Palette

Search for a command to run...

Clinical Trials · NCT00700817

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

CompletedPhase 3Liraglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
665
Start date
Jun 2008
Locations
166 sites, 15 countries
Primary endpoint
Mean Change From Baseline in Glycosylated Haemoglobin A1c (HbA1c) at Week 26
View Liraglutide compound reference